6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
8m ago	Marsh Risk unveils AI-powered Risk Companion suite of analytics to empower clients with faster, smarter risk management
9m ago	Missouri American Water Proudly Recognizes American Water Charitable Foundation 2026 Water and Environment Grantees
9m ago	Protein Alternatives Market Research Report 2026 with Analyst Recommendations and Global Forecast to 2031 Featuring ADM, Beyond Meat, Kerry, Ingredion, Axiom Foods, Impossible Foods, and Cargill
29m ago	XTM Commences Court-Approved Sale and Investment Solicitation Process with Stalking Horse Bid
29m ago	Pfizer Reaches Three Settlement Agreements for VYNDAMAX

About

Appili Therapeutics Inc (TO:APLI) — investor relations, events, news, and company updates on 6ix.

Latest News

Appili Therapeutics to Exhibit at World Vaccine Congress Washington

Appili Therapeutics Announces Closing of Second Tranche of Non-Brokered Private Placement

Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2026

Appili Therapeutics Announces Closing of First Tranche of Non-Brokered Private Placement

The Lundquist Institute and its start-up company Vitalex Biosciences Announces Strategic Advancement of Second-Generation fungal Vaccine VXV-01 through Phase 1 Trials under $40 Million Competitive Contract from NIH/NIAID

Financials

Revenue

CA$206.31 K

Market Cap

CA$2.57 M

EPS

-0.02

Community Chat

Ask AI